| Target Price | $112.20 |
| Price | $56.69 |
| Potential |
97.92%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Vaxcyte Inc 2027 .
The average Vaxcyte Inc target price is $112.20.
This is
97.92%
register free of charge
$171.15
201.91%
register free of charge
$67.67
19.37%
register free of charge
|
|
| A rating was issued by 17 analysts: 15 Analysts recommend Vaxcyte Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Vaxcyte Inc stock has an average upside potential 2027 of
97.92%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -5.63 | -8.52 |
| 48.16% | 51.33% | |
| P/E | negative |
12 Analysts have issued a Vaxcyte Inc forecast for earnings per share. The average Vaxcyte Inc EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Sep 25 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Feb 26 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Feb 02 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Jan 07 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Sep 12 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Apr 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Sep 25 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Feb 26 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Feb 02 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Jan 07 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Sep 12 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Apr 22 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


